In Silico Prediction of the Bioactive Profile and Metabolites of in Diseases Related to the Excessive Production of Interleukin-6

Overview

Journal Bioinform Biol Insights

Publisher Sage Publications

Specialty Biology

Date 2022 Aug 12

PMID 35958296

Authors

Adbelkarim Ezaouine

Mohamed Rida Salam

Badreddine Nouadi

Oumaima Anachad

Mariame El Messal

Fatima Chegdani

Faiza Bennis

Affiliations

Soon will be listed here.

Abstract

Inflammatory bowel diseases are caused by an abnormal reaction of the immune system, which becomes hyperactive because the mechanisms responsible for regulating it get out of control. For an effective immune response, many proinflammatory cytokines are secreted, particularly interleukin-6 (IL-6) keystone cytokine inflammation. Many synthetic and natural compounds targeting IL-6 have been studied. The genus of the Lamiaceae family is generally known for its many virtues, in particular anti-inflammatory properties. However, the mechanism of action is unclear. This study aims to predict the impact of characterized bioactive molecules of Moroccan in the potential control of inflammatory response mediated by IL-6 cytokine. A list of 9 previously characterized natural compounds of was compiled, and a list of 6 potential protein targets involved in intestinal inflammation was made. The 2 lists of natural compound-target proteins were analyzed by the STITCH software (http://stitch.embl.de/) to develop protein-compound and protein-protein interaction networks (PPINs). An ontological enrichment (GO) analysis was performed by the Clue GO plugin to evaluate the PPIN generated by STITCH; finally, the molecular docking to predict the mode underlying the anti-inflammatory effects. STITCH results revealed direct and indirect interactions of chemical compounds with a key protein target IL-6. The array results by ClueGO showed that most compounds involved in the regulation of several biological processes related to IL-6 such as inflammation apoptosis, cell differentiation, and metabolic regulation. The targets directly related to IL-6 have been used for molecular docking. Quercetin, catechin, and gallic acid have a strong affinity with the IL-6 receptor (respectively -7.1; -6.1; -5.3). This study strongly suggests that the bioactive compounds of could constitute a new therapeutic alternative in the treatment of diseases related to IL-6. However, to validate the results obtained in this work, it is necessary to explore the mechanism of action of potential bioactive molecules by experimentation.

Citing Articles

Phenolic Compounds of Therapeutic Interest in Neuroprotection.

Najera-Maldonado J, Salazar R, Alvarez-Fitz P, Acevedo-Quiroz M, Flores-Alfaro E, Hernandez-Sotelo D J Xenobiot. 2024; 14(1):227-246.

PMID: 38390994 PMC: 10885129. DOI: 10.3390/jox14010014.

Flowers as a Potential Natural Resource of Bioactive Molecules: Identification of Anti-Inflammatory Agents and Molecular Docking Analysis.

Damergi B, Essid R, Fares N, Khadraoui N, Ageitos L, Ben Alaya A Molecules. 2023; 28(13).

PMID: 37446858 PMC: 10343631. DOI: 10.3390/molecules28135195.

References

Rauf A, Akram M, Semwal P, Mujawah A, Muhammad N, Riaz Z . Antispasmodic Potential of Medicinal Plants: A Comprehensive Review. Oxid Med Cell Longev. 2021; 2021:4889719. PMC: 8601825. DOI: 10.1155/2021/4889719. View

da Silva A, Coelho P, Amparo J, Alves de Almeida Carneiro M, Borges J, Souza C . The flavonoid rutin modulates microglial/macrophage activation to a CD150/CD206 M2 phenotype. Chem Biol Interact. 2017; 274:89-99. DOI: 10.1016/j.cbi.2017.07.004. View

Chen K, Liu J, Cao X . Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review. J Autoimmun. 2017; 83:1-11. DOI: 10.1016/j.jaut.2017.03.008. View

Chu M, Tsang M, He R, Lam C, Quan Z, Wong C . The Active Compounds and Therapeutic Mechanisms of Pentaherbs Formula for Oral and Topical Treatment of Atopic Dermatitis Based on Network Pharmacology. Plants (Basel). 2020; 9(9). PMC: 7569866. DOI: 10.3390/plants9091166. View

Fechtner S, Singh A, Chourasia M, Ahmed S . Molecular insights into the differences in anti-inflammatory activities of green tea catechins on IL-1β signaling in rheumatoid arthritis synovial fibroblasts. Toxicol Appl Pharmacol. 2017; 329:112-120. PMC: 6686859. DOI: 10.1016/j.taap.2017.05.016. View

Zhou E, Yan F, Li B, Chen M, Tu X, Wu S . Molecular and functional characterization of IL-6 receptor (IL-6R) and glycoprotein 130 (gp130) in Nile tilapia (Oreochromis niloticus). Dev Comp Immunol. 2020; 106:103629. DOI: 10.1016/j.dci.2020.103629. View

Merico D, Isserlin R, Stueker O, Emili A, Bader G . Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One. 2010; 5(11):e13984. PMC: 2981572. DOI: 10.1371/journal.pone.0013984. View

Kishimoto T . IL-6: from its discovery to clinical applications. Int Immunol. 2010; 22(5):347-52. DOI: 10.1093/intimm/dxq030. View

Nishimoto N, Kishimoto T . Inhibition of IL-6 for the treatment of inflammatory diseases. Curr Opin Pharmacol. 2004; 4(4):386-91. DOI: 10.1016/j.coph.2004.03.005. View

10.

Liu S, Luan J, Ding Y . miR-144-3p Targets FosB Proto-oncogene, AP-1 Transcription Factor Subunit (FOSB) to Suppress Proliferation, Migration, and Invasion of PANC-1 Pancreatic Cancer Cells. Oncol Res. 2017; 26(5):683-690. PMC: 7844736. DOI: 10.3727/096504017X14982585511252. View

11.

Cosco D, Failla P, Costa N, Pullano S, Fiorillo A, Mollace V . Rutin-loaded chitosan microspheres: Characterization and evaluation of the anti-inflammatory activity. Carbohydr Polym. 2016; 152:583-591. DOI: 10.1016/j.carbpol.2016.06.039. View

12.

Lin Y, Shi R, Wang X, Shen H . Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets. 2008; 8(7):634-46. PMC: 2615542. DOI: 10.2174/156800908786241050. View

13.

Suzuki T, Hara H . Role of flavonoids in intestinal tight junction regulation. J Nutr Biochem. 2010; 22(5):401-8. DOI: 10.1016/j.jnutbio.2010.08.001. View

14.

Min Y, Choi C, Bark H, Son H, Park H, Lee S . Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflamm Res. 2007; 56(5):210-5. DOI: 10.1007/s00011-007-6172-9. View

15.

Gyamfi J, Eom M, Koo J, Choi J . Multifaceted Roles of Interleukin-6 in Adipocyte-Breast Cancer Cell Interaction. Transl Oncol. 2018; 11(2):275-285. PMC: 5884177. DOI: 10.1016/j.tranon.2017.12.009. View

16.

Kimata M, Shichijo M, Miura T, Serizawa I, Inagaki N, Nagai H . Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin Exp Allergy. 2000; 30(4):501-8. DOI: 10.1046/j.1365-2222.2000.00768.x. View

17.

Maurya D, Nandakumar N, Devasagayam T . Anticancer property of gallic acid in A549, a human lung adenocarcinoma cell line, and possible mechanisms. J Clin Biochem Nutr. 2011; 48(1):85-90. PMC: 3022071. DOI: 10.3164/jcbn.11-004FR. View

18.

Kroes B, van den Berg A, Quarles van Ufford H, Van Dijk H, Labadie R . Anti-inflammatory activity of gallic acid. Planta Med. 1992; 58(6):499-504. DOI: 10.1055/s-2006-961535. View

19.

Kim E, Seo J, Yu J, Lee S, Lim J, Choi J . Anti-Inflammatory Effects of a Polyphenol, Catechin-7,4'--Digallate, from by Regulating NF-κB Signaling Pathway in Mouse Macrophages. Pharmaceutics. 2021; 13(3). PMC: 8003360. DOI: 10.3390/pharmaceutics13030408. View

20.

Kallen K . The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim Biophys Acta. 2002; 1592(3):323-43. DOI: 10.1016/s0167-4889(02)00325-7. View